Angle success with ovarian cancer
17th Apr 2012 10:40
Shares in technology investment firm Angle rose on Tuesday after it said its Parsortix cell separation device had passed an important milestone. The firm said that the device could now capture ovarian cancer cells, creating the possibility of developing an effective, non-invasive screening techniqu
Read moreSmall caps round-up: Top Level Domain, Transense, SkyePharma
11th Apr 2012 09:46
Top Level Domain Holdings, which operates generic top-level domains, has revealed that is wholly-owned subsidiary, Minds and Machines, has been appointed by Dot London Domains (DLD), the official promotional organisation for London, to assist with DLD's application for the position of registry opera
Read moreSmall caps round-up: HMV, Corero, ANGLE ...
15th Mar 2012 12:06
HMV Group, the struggling entertainment media seller, has confirmed that it is still pondering what to do with its live music business. HMV added that a number of parties have indicated an interest in acquiring the business. There has been press speculation recently about who might be interested in
Read moreAngle raises £1.2m, swings to a half-year loss
26th Jan 2012 13:10
Technology investment company ANGLE has raised £1.2m through a fundraising on the same that it revealed it had swung to a loss in the first half ended October 31st. The firm said on Thursday that investors will acquire up to 1,715,717 new ordinary shares in the company at a price of 70p per shar
Read moreAngle makes important step in cancer technology
23rd Jan 2012 14:25
Angle's 90%-owned portfolio company, Parsortix, which specialises in medical diagnostics, has used its cell separation device to successfully capture circulating tumour cells (CTCs) in cancer patient blood. The Parsortix separation technology has already been used to capture cultured breast cancer
Read moreAngle shares storm north on Parsortix lung cancer result
16th Dec 2011 10:37
Angle, the technology investment company, saw its share price go vertical on Friday morning on the back of success at one its investments, Parsortix. Parsortix, which specialises in medical diagnostics, has confirmed its cell separation device can "capture cultured lung cancer cells". This comes af
Read moreAngle reports further delays on IVF product
16th Nov 2011 16:00
Shares in Angle, the Surrey-based technology investment firm, fell today after it reported delays to its IVF product EmbryoSure. The embryo viability product is being developed by Novocellus, which is 82% owned by Angle. The firm had already said the trial of EmbryoSure was delayed, but today adde
Read moreAngle prostate cancer test sees shares rocket
11th Nov 2011 08:21
Angle, the Surrey-based technology investment firm, has seen its share price rocket nearly 15% on news one of its divisions has found a new way to detect prostate cancer. Parsortix, which is 90% owned by Angle, claims its "separation technology" can capture prostate cancer cells added to blood. T
Read moreAngle buys 90% stake in cancer diagnostic firm
5th Oct 2011 14:01
Angle has increased its stake in its subsidiary, Parsotix, to 90% following the success of the cancer diagnostic firm's cell separation device. The fund the move, Angle raised £1.25m in July, 80% of which has been allocated to Parsortix to fund the definitive validation of its initial findings, wh
Read moreAngle announces new cancer detection device
28th Sep 2011 08:38
Technology firm Angle has announced that Parsortix, its 85% owned portfolio company which specialises in medical diagnostics, has achieved a major milestone by validating that its cell separation device can capture cancer cells added to blood. Parsortix's patented cell separation device can be used
Read moreAngle rises sharply on patent award
23rd Aug 2011 12:12
Technology firm incubator Angle saw an acute increase in its share price after one of its subsidiaries was granted a US patent. Angle's 83% owned medical diagnostics company Parsortix has been issued a US patent relating to its technology for particle and cell separation, identification, sorting an
Read moreAngle FY10 Loss Narrows, To Focus On Cash Resources, Cost Cuts
29th Jul 2010 08:21
LONDON (Dow Jones)--Angle PLC (AGL.LN), an international Ventures and Management services company, Thursday reported a much narrowed fiscal 2010 pretax loss and said it continues to focus on the level of cash resources available to it and will continue to reduce its cost base and seek new management
Read moreAngle investment secures high profile partner
26th Jul 2010 17:14
Technology consultancy and investment company Angle says that its portfolio company Geomerics has agreed a corporate partnership with one of the world's leading technology companies. The partner will invest up to £2.3m in Geomerics, of which £1m is dependent on milestones being achieved. Angle cu
Read moreAngle: Geomerics Corporate Partnership With Technology Company
26th Jul 2010 08:24
LONDON (Dow Jones)--Angle PLC (AGL.LN), an international venture management company focusing on the commercialization of technology and innovation, said Monday that its portfolio company Geomerics Ltd, which specializes in computer games middleware, has agreed to a corporate partnership with a techn
Read moreSmall caps round-up: Judges Scientific, Terra Catalyst, DCC
16th Jul 2010 11:42
Judges Scientific said trading activity during the six-month ended 30 June remained robust and benefited from a healthy opening order book, strong order intake and favourable exchange rates. Order intake during the half-year was much stronger than in the comparable period of 2009. Terra Catalyst Fu
Read more